Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China · Delayed Price · Currency is CNY 37.10
-1.56 (-4.04%)
Nov 6, 2026, 11:14 AM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 5.43 billion as of November 5, 2026. It is the 11,122nd most valuable company in the world and the 2,670th biggest in China. Its market cap has decreased by 9.29% in one year.
Market Cap
5.43B
Enterprise Value
4.30B
Revenue
452.12M
Global Rank
Country Rank
#2,670 China
PE Ratio
500.45
ChartMarket Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 5.43B, a decrease of -34.02%. That is a compound annual growth rate of -7.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 5.43B | -1.80% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
| Sep 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovita Biological Technology | 6.57B |
| Beijing Hotgen Biotech | 6.08B |
| Zhejiang Ausun Pharmaceutical | 5.92B |
| R&G PharmaStudies | 5.54B |
| PharmaResources (Shanghai) | 5.49B |
| Wuhan Keqian Biology Co.,Ltd | 5.40B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.19B |
| Youcare Pharmaceutical Group | 4.99B |